Month 2 on finasteride and your hair looks worse. Here's why that's the drug working.

It's week 6. You're shedding more than before you started. Pillow looks worse. Drain looks worse. The mirror panic is real.

The drug is working.

The shed isn't finasteride failing. It's miniaturized follicles getting kicked out of extended telogen so the regrown anagen cycle can run. Reddit calls it "fin shed." Pharmacology calls it anagen synchronization. Most people quit at month 2-3 — exactly the wrong moment.

A 30-second briefing on the hair cycle.

Each follicle on your scalp cycles through three phases.

Anagen — active growth, 2-7 years. About 85% of a normal scalp's hairs sit here at any given moment.

Catagen — transitional shutdown, 2-3 weeks. About 1%.

Telogen — resting, then shedding. 3-4 months. About 14%. Normal scalp loses ~100 hairs/day from this pool. That's not loss; that's turnover.

A DHT-affected follicle distorts this cycle. Anagen shortens. Telogen lengthens and gets stickier — old hairs hang on past normal exit. The follicle itself miniaturizes: shorter, thinner, less pigmented output. From outside, density drops slowly over years. From inside, follicles are stuck shipping smaller hairs out of a longer rest.

Now you take finasteride.

What finasteride actually does, week by week.

Week 1-2. Serum DHT drops 60-70% on ongoing dosing (Drake 1999 measured at 42 days; single-dose PK shows the suppression establishes quickly within the first day). Scalp DHT — the local tissue concentration that matters for hair — takes longer because there's a stored depot to deplete. Nothing visible on your head yet.

Week 4-12. The shed. The miniaturized follicles that were stuck in extended telogen — held there partly by DHT signaling — get released. They shed early to clear room for the new anagen cycle that's about to start. To you, looking down at the pillow, this looks like worse hair. To the follicle, it's a forced reset. The bad hair is leaving so the better hair can come in. This is the signal that the drug is working, not the signal that it isn't.

Week 12-24. Released follicles enter anagen. The first new shafts coming up are vellus — fine, peach-fuzz hair. The scalp may feel slightly denser to the touch before it looks denser in photos. You won't be able to see this in a mirror at month 4. A camera, with stable lighting, will catch it before your eye does.

Month 6-12. Vellus matures into terminal hair. This is the first phase you can actually see in a side-by-side photo. Density gain is real and measurable now.

Month 12-24. Plateau. Maximum response to monotherapy. Whatever you're going to get from finasteride 1mg, you've mostly got by month 18-24.

The Kaufman 1998 PROPECIA trials (JAAD 1998;39(4 Pt 1):578-589) established this timeline in 1,553 men: visual improvement starts in a minority by month 6, majority by month 12, plateau at year 2. The shed window in months 1-3 is the price of admission, not a refund signal.

What Reddit gets wrong (and partly right).

r/Tressless has tens of thousands of threads with the same shape: "I'm 8 weeks in, shedding more than ever, should I quit?" Most replies say wait it out. The replies are right.

The selection bias is hidden but brutal: the people who quit at month 2-3 don't post month-12 success stories — because they didn't have one. The shed graveyard is the cohort that didn't post the win. Survivors-only data on a forum looks like "everyone made it through." Everyone who's still here made it through. The quitters are silent.

Reddit also sometimes labels onset shed "PFS shed." It isn't. PFS — post-finasteride syndrome — is persistence of sexual, cognitive, or mood symptoms after stopping the drug. Post-marketing estimates range 0.2-5% depending on registry, with FDA AERS analyses (Belknap SM et al. JAMA Dermatology 2015;151(6):600-606) reporting in the 2-5% range; Healy 2022 (Int J Risk Saf Med) is the diagnostic-criteria framework. PFS is a discontinuation phenomenon, systemic, not hair. Onset shed is a hair phenomenon happening while you're on the drug. The two share nothing except that both spook people into quitting.

Onset shed is the smoke from the fire burning dead follicles out. PFS is a separate, rarer, darker conversation. (Full PFS-vs-onset-shed math here.)

The shed graph, month by month.

What users actually see, plotted week against panic:

• Month 0 — baseline. Photo this. Three angles, identical lighting, same time of day. You will need this in 6 months.
• Month 1 — slight shed increase, often subtle. Sometimes nothing.
• Month 2 — shed peak. Pillow worse. Drain worse. Scalp may look thinner because synchronized telogen exit is concentrated.
• Month 3 — shed plateau. This is where most quitters quit.
• Month 4-6 — shed normalizes back to baseline. No visible improvement yet. Mirror still looks the same as month 3. This is the dead zone.
• Month 6 — first "is something happening?" moment. Vellus hair visible at the temples or hairline if you look hard with side lighting.
• Month 9-12 — visible improvement on a fixed-condition photo comparison. Not in the mirror at 7am — in a photo, against your month-0 photo.

The biggest enemy isn't the drug. It's the timeline. You're being asked to absorb visible worsening for 8-12 weeks before a 6-month silent phase before the first real signal. Your monkey brain reads month 2 and concludes the drug is failing. The data says month 2 is the drug working at the only timing it can work.

Normal onset shed vs concerning shed — diagnostic.

Most onset sheds are normal. Some aren't. The crude filter:

Normal onset shed. 100-300 hairs/day for 2-12 weeks. Mostly miniaturized vellus shedding (short, fine, lighter). No scalp itch or burn. No patchy bald areas. Resolves by month 4. No systemic symptoms.

Concerning shed (not just AGA). Shed counts persistently elevated past 3 months (often >300/day in clinical reports). Mostly terminal hair (thick, dark, full-length) — not the vellus you'd expect from synchronized exit. Patchy areas. Scalp inflammation, itching, burning, redness. Often paired with fatigue, dry skin, weight changes, recent illness, recent crash diet, or significant life stress.

Concerning shed is often telogen effluvium from a separate cause — thyroid, ferritin, vitamin D deficiency, illness, post-surgical, post-COVID, post-pregnancy. See a derm. Order labs: TSH, ferritin, 25-OH vitamin D. Add RPR if patchy loss is present (rules out secondary syphilis) — not standard for diffuse onset shed. Don't blame the finasteride for what the iron panel was already going to find.

What to do during the onset shed (the real protocol).

Don't quit. Quitting at month 2 means you ate the shed cost without ever getting to the regrowth benefit. You bought the bad half of the trade.

Don't add minoxidil mid-shed. Minoxidil has its own shed via a different mechanism — shortens telogen, forces dormant follicles into anagen, kicks out the loose telogen hair (mechanism originally described in Headington 1993 Arch Dermatol 129(3):356-363 on telogen-to-anagen synchronization; safety/onset profile in low-dose oral minoxidil confirmed by Vañó-Galván 2021 JAAD, PMID 33639244). Stack-onset double shed lands month 2-3 and looks apocalyptic. People panic and quit both.

Do photograph weekly. Same three angles, same lighting, same time of day. You're collecting data. The shed peak is typically week 6-10. Knowing where you are on the curve removes 80% of the panic.

Do count strands once. Pillow at month 0, month 1, month 2. When the mirror panics in week 8, the numbers anchor you: shed peaked, resolving on schedule, this is what I signed up for.

Do NOT switch from oral to topical mid-shed. Same molecule, no reset benefit. The shed is intrinsic to the molecule's mechanism, not the route. Topical fin sheds the same way oral fin does, on the same calendar.

Order matters: fin first, then minoxidil 8-12 weeks later.

Both drugs cause onset sheds. Both sheds are pharmacological signals of the drug working. Neither is failure.

Start them simultaneously and you hit the double-shed window in months 2-3. Brutal but normal. It doubles your quit risk because you can't tell which drug is "doing it" and your brain will offer to scrap both.

A smoother psychological onboarding: start finasteride first, wait 8-12 weeks for the fin shed to plateau, then add minoxidil. You absorb one shed at a time. The minoxidil shed lands when the fin shed is already resolving. (Oral minoxidil 2.5mg dose math and shed window detail here.)

And about the price.

A 30-pack of finasteride 1mg, US side:

The shed is free regardless of where you bought. The only thing price changes is whether quitting at month 2 cost you $44 (Hims, two months) or $14 (Walmart cash, two months). Drug behavior is identical. (Hims $22 markup teardown.) (5-brand finasteride teardown.)

The cheapest legitimate US lane isn't us — it's Walmart cash with a SingleCare coupon, if you have a PCP willing to write the script. The personal-import lane (us, or equivalent) fits people without a PCP, with privacy needs, or who want a 90-day pack instead of monthly autorefill. Pick the lane that matches.

Action — the real onboarding protocol.

Day 0. Photo baseline. Three angles — top of head, front hairline, crown. Identical lighting, same time of day. Save in a folder labeled with the date.

Week 1-4. Take the pill. Photo weekly. Don't compare yet — the eye can't see anything real this early.

Week 4-12 — the shed. Don't quit. Photo continues. One question: is my shed >300 hairs/day for >12 weeks, or is scalp inflammation / patchy loss / fatigue paired with it? If no, hold. If yes, see a derm and order TSH / ferritin / 25-OH vitamin D (add RPR only if patchy loss).

Month 4-6. Re-evaluate at the fixed checkpoint. Compare your month-0 photo to your month-6 photo — never yesterday to today. Mirror noise is too high; photos are how you see signal.

Month 6. If scalp looks worse and shed hasn't normalized — derm visit. May not be just AGA.

Month 12. If still no improvement on photo comparison — blood work (DHT level, full thyroid panel, ferritin), consider escalating to dutasteride. (Full fin-to-dut escalation math here.)

The single most common reason finasteride "fails" is that the user quit during onset shed, never gave the drug the 12-month window required to see signal, and concluded the molecule didn't work. The molecule was working in week 8. The user just left before the window opened.

A note on bias.

We route finasteride orders. Be aware of that.

LiberaCure routes orders to licensed personal-import pharmacies. Finpecia (by Cipla — the WHO-prequalified Indian giant that supplies most of LMIC HIV/TB drugs) is the finasteride 1mg SKU we ship most often, alongside Curlzfin (by Canixa Life Sciences) at the lower price tier. The longer you stay on finasteride, the more you spend with us. So we have a financial reason to want this article to keep you on at month 2-3.

Read this with that in mind. The protocol above is what I'd tell a friend, not what maximizes reorder rate. The pharmacology of the shed is the same whether you bought the pill from us, from Walmart at $4 with a coupon, or from Hims at $22. The molecule doesn't know whose box it came in. The shed math is identical regardless. If your supplier already works for you and the price is in the same band, don't switch on $0.05 per pill. A working supplier is worth more than that.

For where finasteride sits in the broader hair-loss treatment hierarchy (Big 3 = fin + minoxidil + ketoconazole, plus the optional 20%): our hair-loss pillar guide covers the full ladder.

Sources:

• Kaufman KD et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578-589. (PROPECIA pivotal — onset and 12-month timeline.)
• Drake LA et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999;41(4):550-554. (Dose-response, scalp DHT depletion kinetics.)
• Olsen EA. Disorders of Hair Growth: Diagnosis and Treatment — clinical hair cycle reference (anagen/catagen/telogen percentages, telogen effluvium diagnostics).
• Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol 1993;129(3):356-363. PMID 8447677 (Original mechanistic description of telogen-to-anagen synchronization shed — applies to minoxidil-induced shed and to onset shed in general.)
• Vañó-Galván S et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol 2021. PMID 33639244 (Low-dose oral minoxidil safety, onset shed timing in modern cohort.)
• Belknap SM et al. Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis. JAMA Dermatology 2015;151(6):600-606. (Adverse event prevalence framing for PFS-range estimates.)
• Healy D et al. Post-finasteride syndrome and persistent sexual dysfunction. Int J Risk Saf Med 2022 — diagnostic-criteria framework for PFS, used here for the PFS-vs-onset-shed boundary (not for prevalence).
• Hims, Keeps, Roman, CVS, Walmart/SingleCare/GoodRx finasteride retail cash pricing, May 2026 snapshot. Re-verify before citing.

— LiberaCure editorial. We route generic medication through licensed personal-import pharmacies. We don't dispense, prescribe, or warehouse. Read more about why.